Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T15:46:29.865Z.
Calculation as of: 2026-10-06T15:46:29.865Z.
Quote observation: 2026-10-06T15:41:41.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d814f2f9bb590440d28c37f6667649cf2cd18fb847665efd301ef7281cbad61c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$2.73M
Price/FCF Ratio
22.27
TTM Avg
83.70
3Y Avg
7795.06
5Y Avg
7795.06
Market Cap
$2.90M
Price/FCF Ratio
N/A
TTM Avg
100.17
3Y Avg
2478.31
5Y Avg
2478.31
Market Cap
$3.10M
Price/FCF Ratio
N/A
TTM Avg
2.54
3Y Avg
2.54
5Y Avg
2.54
Market Cap
$3.14M
Price/FCF Ratio
N/A
TTM Avg
1508.93
3Y Avg
1508.93
5Y Avg
1508.93
Market Cap
$2.27M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Top KingWin Ltd. Class A (DPU) | $2.73M | N/A | N/A | N/A | N/A |
| Globavend Holdings Limited (GVH)vs › | $2.73M | 22.27 | 83.70 | 7795.06 | 7795.06 |
| DEFSEC Technologies Inc. (DFSC)vs › | $2.69M | N/A | N/A | N/A | N/A |
| BioNexus Gene Lab Corp. (BGLC)vs › | $2.90M | N/A | 100.17 | 2478.31 | 2478.31 |
| Intelligent Group Limited (INTJ)vs › | $3.10M | N/A | 2.54 | 2.54 | 2.54 |
| PTL Limited (PTLE)vs › | $3.10M | N/A | N/A | N/A | N/A |
| Polar Power, Inc. (POLA)vs › | $3.14M | N/A | 1508.93 | 1508.93 | 1508.93 |
| Iveda Solutions, Inc. (IVDA)vs › | $3.30M | N/A | N/A | N/A | N/A |
| Ping An Biomedical Co., Ltd. (PASW)vs › | $2.27M | N/A | N/A | N/A | N/A |
| Addentax Group Corp. (ATXG)vs › | $3.36M | N/A | 4.88 | 5.73 | 47.79 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
